FDA approves Alzheimer's drug against the recommendation of its scientific panel. Be very concerned.

Authors

  • Joshua Freeman, MD

DOI:

https://doi.org/10.17161/rrnmf.v2i5.15979

Keywords:

Alzheimers, FDA

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Downloads

Published

2021-12-20

Issue

Vol. 2 No. 5 (2021)

Section

What’s on your Mind: Commentaries (Letters to the Facilitators)

License

Copyright (c) 2021 Joshua Freeman

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Freeman, MD, J. (2021). FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned. RRNMF Neuromuscular Journal, 2(5), 5-6. https://doi.org/10.17161/rrnmf.v2i5.15979